Massimo Cristofanilli

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Criscitiello, Carmen, Cristofanilli, Massimo, Daniel Birnbaum, Lukas Weiss, M CRISTOFANILLI, M Cristofanilli, M. Cristofanilli, M.A. Cristofanilli, MASSIMO CRISTOFANILLI, Massimo Cristofanilli

1.4K

Publications

57.1K

Citations

111

H-Index

165

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Northwestern University Fox Chase Cancer Center Robert H. Lurie Comprehensive Cancer Center of Northwestern University Thomas Jefferson University

About

Massimo Cristofanilli is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	55	137	11.6K
2	Health Sciences	18	25	3.3K
3	Engineering	7	7	451
4	Nursing	3	3	135
5	Natural Sciences	1	1	38

Massimo Cristofanilli

352

Publications

49.9K

Citations

H-Index

Page 1

	Year	Citations
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, New England Journal of Medicine	2004	4.5K
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Journal of Clinical Oncology	2008	2.9K
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy Roman Rouzier, Charles M. Perou, W. Fraser Symmans, Clinical Cancer Research	2005	1.9K
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial Massimo Cristofanilli, Nicholas C. Turner, Igor Bondarenko, The Lancet Oncology Breast OncologyHealth SciencesMedicinePharmacologyClinical Trials	2016	1.8K
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer Nicholas C. Turner, Jungsil Ro, Fabrice André, New England Journal of Medicine	2015	1.5K
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System Sabine Riethdorf, Herbert A. Fritsche, Volkmar Müller, Clinical Cancer Research	2007	1.3K
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer Nicholas C. Turner, Dennis J. Slamon, Jungsil Ro, New England Journal of Medicine	2018	1.2K
Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis, Journal of Clinical Oncology	2005	1.2K
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer Massimo Cristofanilli, Daniel F. Hayes, G. Thomas Budd, Journal of Clinical Oncology	2005	1.1K
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival Daniel F. Hayes, Massimo Cristofanilli, G. Thomas Budd, Clinical Cancer Research	2006	1K

Page 1